Invention Grant
- Patent Title: BCMA antigen binding proteins
- Patent Title (中): BCMA抗原结合蛋白
-
Application No.: US14098275Application Date: 2013-12-05
-
Publication No.: US09243058B2Publication Date: 2016-01-26
- Inventor: Richard J. Armitage , Michelle Blake , William C. Fanslow, III , Jason Charles O'Neill , Gunasekaran Kannan , Jiangchun Xu , Mark Edward Tometsko
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen, Inc.
- Current Assignee: Amgen, Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Nathan A. Machin
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K45/06 ; A61K47/48 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
Public/Granted literature
- US20140161828A1 BCMA ANTIGEN BINDING PROTEINS Public/Granted day:2014-06-12
Information query
